# Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex

> **NCT05794503** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 235 (actual)

## Conditions studied

- Urinary Retention Postoperative
- Laparoscopic Cholecystectomy
- Neuromuscular Blockade
- Sugammadex
- Neostigmine
- Neuromuscular Blocking Agents
- Physiological Effects of Drugs

## Interventions

- **DRUG:** Neostigmine
- **DRUG:** Sugammadex

## Key facts

- **NCT ID:** NCT05794503
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-11
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05794503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05794503, "Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05794503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*